These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8521904

  • 21. Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake.
    Tomkins DM, Higgins GA, Sellers EM.
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):173-9. PubMed ID: 7862892
    [Abstract] [Full Text] [Related]

  • 22. Repeated corticosterone treatment attenuates behavioural and neuroendocrine responses to 8-hydroxy-2-(di-n-propylamino) tetralin in rats.
    Haleem DJ.
    Life Sci; 1992 Jun; 51(23):PL225-30. PubMed ID: 1435084
    [Abstract] [Full Text] [Related]

  • 23. The effects of adrenalectomy and ovariectomy on the behavioral and hypothermic responses of rats to 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT).
    Young AH, Dow RC, Goodwin GM, Fink G.
    Neuropharmacology; 1993 Jul; 32(7):653-7. PubMed ID: 8361580
    [Abstract] [Full Text] [Related]

  • 24. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 25. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The 5-HT1A receptor agonist 8-OH-DPAT reduces ethanol intake and maintained behavior in female Sprague-Dawley rats.
    Wilson AW, Neill JC, Costall B.
    Alcohol; 1996 Jul 01; 13(5):407-13. PubMed ID: 8888935
    [Abstract] [Full Text] [Related]

  • 28. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 01; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 29. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG.
    Eur J Pharmacol; 1990 Feb 13; 176(3):331-40. PubMed ID: 1970304
    [Abstract] [Full Text] [Related]

  • 30. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 13; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Circadian rhythm in the response to intracerebroventricular administration of 8-OH-DPAT.
    Nagayama H, Lu JQ.
    Brain Res; 1997 May 09; 756(1-2):92-5. PubMed ID: 9187318
    [Abstract] [Full Text] [Related]

  • 34. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS, Lucki I.
    Synapse; 1997 Feb 09; 25(2):107-16. PubMed ID: 9021891
    [Abstract] [Full Text] [Related]

  • 35. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
    Hillegaart V, Hjorth S.
    Eur J Pharmacol; 1989 Jan 31; 160(2):303-7. PubMed ID: 2527161
    [Abstract] [Full Text] [Related]

  • 36. An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT.
    Blanchard RJ, Shepherd JK, Armstrong J, Tsuda SF, Blanchard DC.
    Psychopharmacology (Berl); 1993 Jan 31; 112(1):55-63. PubMed ID: 7871010
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep 31; 181(2):381-91. PubMed ID: 15830225
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y, Yamawaki S.
    Yakubutsu Seishin Kodo; 1987 Sep 31; 7(3):383-92. PubMed ID: 2894736
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.